Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
Holders of 5% or more of BCRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biocryst Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.40%17.5M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Flynn James E | 13G/A | 6.81%14.3M shares | +1.01 ppfrom 5.80% | Sep 19, 20252 filings | Feb 12, 2026 | SEC |
| Ra Capital Management, L.P. | 13G/A | 6.20%15.8M shares | −1.10 ppfrom 7.30% | Nov 12, 20252 filings | Aug 14, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.16%13.0M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
40 Schedule 13D and 13G filings on Biocryst Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20266:38 AM ET | State Street Corp | 13G | 4.80%12.3M shares | −1.20 ppfrom 6.00%Below 5% | Sep 30, 2026 | SEC |
| Aug 14, 20264:39 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 6.20%15.8M shares | −1.10 ppfrom 7.30% | Jun 30, 2026 | SEC |
| Aug 7, 20268:48 AM ET | State Street Corp | 13G | 6.00%15.2M shares | +1.10 ppfrom 4.90% | Jun 30, 2026 | SEC |
| May 12, 20269:59 AM ET | State Street Corp | 13G | 4.90%12.2M shares | −0.40 ppfrom 5.30%Below 5% | Mar 31, 2026 | SEC |
| Apr 29, 20265:02 PM ET | Vanguard Capital Management LLC | 13G | 5.16%13.0M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20264:09 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 12, 20262:17 PM ET | Flynn James Eand 3 others | 13G/A | 6.81%14.3M shares | +1.01 ppfrom 5.80% | Dec 31, 2025 | SEC |
| Feb 9, 20266:19 AM ET | State Street Corp | 13G | 5.30%11.1M shares | – | Dec 31, 2025 | SEC |
| Nov 12, 20258:27 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 7.30%15.3M shares | New | Nov 4, 2025 | SEC |
| Sep 19, 202512:23 PM ET | Flynn James Eand 3 others | 13G | 5.80%12.2M shares | New | Sep 12, 2025 | SEC |
| May 15, 20259:31 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 4.20%8.70M shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 8.40%17.5M shares | – | Mar 31, 2025 | SEC |
| Nov 7, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Oct 17, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Sep 10, 202412:09 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Avoro Capital Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20245:23 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 24, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20234:27 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Apr 12, 2021 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2021 | State Street Corp | 13GOld format | – | New | – | SEC |
| Jan 28, 20215:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 2021 | Sarissa Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
20 notices from officers, directors and other affiliates planning to sell Biocryst Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| May 18, 20264:48 PM ET | Amy McKeeDirector | 11.2K | $99.9K | May 18, 2026 | Merrill Lynch | SEC |
| May 13, 20261:06 PM ET | Barnes Alane POfficer | 62.5K | $596.3K | May 13, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 20, 202611:36 AM ET | Heggie TheresaDirector | 49.9K | $504.6K | Mar 20, 2026 | Fidelity Brokerage Services LLC | SEC |
| Mar 16, 20264:17 PM ET | Barnes Alane POfficer | 150.0K | $1.37M | Mar 16, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 2, 20263:16 PM ET | Stonehouse Jon PDirector | 306.0K | $2.65M | Mar 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Dec 22, 20251:27 PM ET | Barnes Alane POfficer | 21.8K | $166.6K | Dec 22, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| Dec 15, 202510:48 AM ET | Barnes Alane POfficer | 21.2K | $162.3K | Dec 15, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| Dec 3, 20252:01 PM ET | Barnes Alane POfficer | 19.8K | $151.2K | Dec 3, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| Dec 2, 20252:09 PM ET | Barnes Alane POfficer | 50.9K | $367.2K | Dec 2, 2025 | Fidelity Brokerage Services LLC | SEC |
| Dec 1, 202512:51 PM ET | Barnes Alane POfficer | 91.0K | $644.3K | Dec 1, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| Nov 25, 20254:31 PM ET | Helen M ThackrayOfficer | 48.2K | $328.0K | Nov 25, 2025 | Merrill Lynch | SEC |
| Nov 21, 20254:29 PM ET | Helen ThackrayOfficer | 43.3K | $307.7K | Nov 21, 2025 | Merrill Lynch | SEC |
| Nov 13, 202510:21 AM ET | Sanders MachelleOfficer | 9.60K | $68.5K | Nov 13, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| Aug 13, 202512:17 PM ET | Heggie TheresaDirector | 70.0K | $595.9K | Aug 13, 2025 | Fidelity Brokerage Services LLC | SEC |
| Dec 13, 20244:23 PM ET | Hutson Nancy JDirector | 7.00K | $52.6K | Dec 13, 202410b5-1 | Merrill Lynch | SEC |
| Jun 24, 20244:11 PM ET | McKee Amy EDirector | 8.60K | $54.1K | Jun 24, 2024 | Merrill Lynch | SEC |
| Jun 17, 20244:14 PM ET | Sanders MachelleDirector | 4.69K | $28.0K | Jun 17, 2024 | Merrill Lynch | SEC |
| Jun 14, 20244:08 PM ET | Heggie TheresaDirector | 6.70K | $40.7K | Jun 14, 2024 | Merrill Lynch | SEC |
| Jun 15, 202310:19 AM ET | Sanders MachelleOfficer | 4.00K | $31.8K | Jun 15, 2023 | Merrill Lynch | SEC |
| Jun 14, 202311:32 AM ET | Hutson Nancy JOfficer | 12.9K | $104.0K | Jun 14, 2023 | Merrill Lynch | SEC |